Literature DB >> 5535608

Clinical experience with thiocarlide (Isoxyl).

B Urbancik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5535608     DOI: 10.1159/000386811

Source DB:  PubMed          Journal:  Antibiot Chemother


× No keyword cloud information.
  7 in total

1.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.

Authors:  Benjawan Phetsuksiri; Mary Jackson; Hataichanok Scherman; Michael McNeil; Gurdyal S Besra; Alain R Baulard; Richard A Slayden; Andrea E DeBarber; Clifton E Barry; Mark S Baird; Dean C Crick; Patrick J Brennan
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

3.  A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.

Authors:  Anna E Grzegorzewicz; Jana Korduláková; Victoria Jones; Sarah E M Born; Juan M Belardinelli; Adrien Vaquié; Vijay A K B Gundi; Jan Madacki; Nawel Slama; Françoise Laval; Julien Vaubourgeix; Rebecca M Crew; Brigitte Gicquel; Mamadou Daffé; Hector R Morbidoni; Patrick J Brennan; Annaik Quémard; Michael R McNeil; Mary Jackson
Journal:  J Biol Chem       Date:  2012-09-21       Impact factor: 5.157

4.  Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis.

Authors:  Jana Korduláková; Yves L Janin; Avraham Liav; Nathalie Barilone; Tiago Dos Vultos; Jean Rauzier; Patrick J Brennan; Brigitte Gicquel; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

5.  EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.

Authors:  Lynn G Dover; Anuradha Alahari; Paul Gratraud; Jessica M Gomes; Veemal Bhowruth; Robert C Reynolds; Gurdyal S Besra; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

6.  A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets.

Authors:  Daniel Zamith-Miranda; Heino M Heyman; Meagan C Burnet; Sneha P Couvillion; Xueyun Zheng; Nathalie Munoz; William C Nelson; Jennifer E Kyle; Erika M Zink; Karl K Weitz; Kent J Bloodsworth; Geremy Clair; Jeremy D Zucker; Jeremy R Teuton; Samuel H Payne; Young-Mo Kim; Morayma Reyes Gil; Erin S Baker; Erin L Bredeweg; Joshua D Nosanchuk; Ernesto S Nakayasu
Journal:  mBio       Date:  2021-11-23       Impact factor: 7.867

7.  The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatis.

Authors:  Stevie Jamet; Nawel Slama; Joana Domingues; Françoise Laval; Pauline Texier; Nathalie Eynard; Annaik Quémard; Antonio Peixoto; Anne Lemassu; Mamadou Daffé; Kaymeuang Cam
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.